Xue Wang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
Papers in
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6
- Breast Cancer Treatment Studies 5
-
- Phytochemicals and Antioxidant Activities 5
- Journals
- Water (4 papers)Phytomedicine (4 papers)Scientific Reports (3 papers)ACS Applied Materials & Interfaces (3 papers)Brain Research (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xue Wang
123 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 142
- Cancer Research 381
- Molecular Biology 968
- Pharmacology 105
- Complementary and alternative medicine 95
- Biological Psychiatry 27
Countries citing papers authored by Xue Wang
This map shows the geographic impact of Xue Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Wang more than expected).
Fields of papers citing papers by Xue Wang
This network shows the impact of papers produced by Xue Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Wang. The network helps show where Xue Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xue Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 3 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 5 | |
| 7 | 2025 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 3 | |
| 10 | 2024 | 3 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 0 | |
| 13 | 2022 | 22 | |
| 14 | 2021 | 39 | |
| 15 | 2021 | 1 | |
| 16 | 2020 | 24 | |
| 17 | Anti-PD1 up-regulates PD-L1 expression and inhibits T-cell lymphoma progression: possible involvement of an IFN-γ-associated JAK-STAT pathway | 2019 | 2 |
| 18 | The effect of MTHFD2 on the proliferation and migration of colorectal cancer cell lines | 2019 | 1 |
| 19 | 2018 | 32 | |
| 20 | 2018 | 46 |
About Xue Wang
Xue Wang is a scholar working on Cancer Research, Biochemistry, Molecular Biology, Biochemistry and Clinical Biochemistry, having authored 148 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), Metabolomics and Mass Spectrometry Studies (6 papers), MicroRNA in disease regulation (6 papers), Mitochondrial Function and Pathology (6 papers), Cancer-related molecular mechanisms research (6 papers), Breast Cancer Treatment Studies (5 papers), Phytochemicals and Antioxidant Activities (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (381 citations), Molecular Biology (968 citations), Pharmacology (105 citations), Complementary and alternative medicine (95 citations) and Biological Psychiatry (27 citations). Xue Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Pintong Huang, Jiawei Pei, Chaofei Yang, Ye Tian, Airong Qian, Peihong Su, Xiaoli Ma, Yiqing Zeng, Yu Sun and Jing Cao. Their work appears in journals such as Water, Phytomedicine, Scientific Reports, ACS Applied Materials & Interfaces and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.